Anaplastic large cell lymphoma (ALCL), ALK-positive, is a rare type of non-Hodgkin lymphoma characterized by the presence of anaplastic lymphoma kinase (ALK) gene rearrangements. This subtype primarily affects lymphoid tissues, including the spleen, and is associated with aggressive clinical behavior. Accurate coding with ICD-10 Code C84.67 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.
What is ICD-10 Code C84.67 for Anaplastic large cell lymphoma, ALK-positive, spleen?
ICD-10 Code C84.67 specifically denotes Anaplastic large cell lymphoma, ALK-positive, affecting the spleen. This code is utilized when documenting cases of ALCL that exhibit ALK gene rearrangements, which are critical for diagnosis and treatment planning. It is essential for accurate clinical documentation and billing, particularly in oncology settings.
ICD-10 Code C84.67 – Clinical Definition and Explanation of Anaplastic large cell lymphoma, ALK-positive, spleen
Anaplastic large cell lymphoma, ALK-positive, is a hematological malignancy that arises from T-cells and is characterized by the presence of the ALK gene rearrangement. This condition can lead to significant splenic involvement and requires prompt medical intervention due to its aggressive nature.
Key Clinical Features:
- Presence of ALK gene rearrangement detected via genetic testing.
- Common symptoms include lymphadenopathy, splenomegaly, and systemic symptoms such as fever and weight loss.
- Typically affects younger adults and children, with a higher prevalence in males.
- Aggressive clinical course necessitating early diagnosis and treatment.
ICD-10 Code C84.67 for Anaplastic large cell lymphoma, ALK-positive, spleen – SOAP Notes & Clinical Use
ICD-10 Code C84.67 is integral in SOAP notes for documenting the clinical presentation, assessment, and treatment of patients with Anaplastic large cell lymphoma, ALK-positive, affecting the spleen. It aids in tracking patient progress and ensuring appropriate care in both acute and chronic settings.
What Does ICD-10 Code C84.67 for Anaplastic large cell lymphoma, ALK-positive, spleen Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C84.67 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-positive, affecting the spleen. This ensures continuity of care and supports accurate billing and documentation standards.
Treatment Options for ICD-10 Code C84.67 – Anaplastic large cell lymphoma, ALK-positive, spleen
Management of Anaplastic large cell lymphoma, ALK-positive, requires urgent medical intervention, often necessitating hospitalization for intensive treatment.
Antibiotic Therapy:
- Not applicable as this is not an infectious condition; treatment focuses on chemotherapy and targeted therapy.
Supportive Care:
- Management of symptoms such as pain and fever.
- Nutritional support to maintain strength during treatment.
- Psychosocial support for patients and families.
Infection Control:
- Standard precautions to prevent infections due to immunosuppression.
- Monitoring for signs of infection during chemotherapy.
How to Document Symptoms of Anaplastic large cell lymphoma, ALK-positive, spleen (ICD-10 C84.67) in SOAP Notes
Subjective:
- Patient reports persistent fatigue and unexplained weight loss.
- Complaints of night sweats and fever.
- Notable increase in abdominal girth due to splenomegaly.
Objective:
- Physical examination reveals splenomegaly and lymphadenopathy.
- Laboratory tests show elevated lactate dehydrogenase (LDH) levels.
- Imaging studies confirm splenic involvement.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Anaplastic large cell lymphoma, ALK-positive, spleen (ICD-10 Code C84.67)
Assessment:
- Diagnosis: Anaplastic large cell lymphoma, ALK-positive, spleen, classified as aggressive.
- ICD-10 Code: C84.67.
- Contributing factors include age and gender predisposition.
Plan:
- Initiate chemotherapy regimen targeting ALK-positive cells.
- Educate patient on potential side effects and the importance of follow-up.
- Schedule regular monitoring of blood counts and imaging studies.
Treatment & Plan Section for ICD-10 Code C84.67 – Anaplastic large cell lymphoma, ALK-positive, spleen
- First-line treatment includes chemotherapy regimens such as CHOP or targeted therapy with crizotinib.
- Non-pharmacologic strategies include nutritional support and psychosocial counseling.
- Monitoring includes regular blood tests to assess response to treatment and detect complications.
- Follow-up appointments should be scheduled every 1-3 months post-treatment.
Using ICD-10 Code C84.67 for Anaplastic large cell lymphoma, ALK-positive, spleen in Billing & SOAP Note Compliance
- Ensure clear documentation of symptoms and clinical findings under Subjective (S) and Objective (O) sections.
- Align treatment plans with clinical guidelines to support justified billing.
- Utilize C84.67 in all relevant encounters to maintain coding accuracy.
- Document any complications or comorbidities that may affect treatment and billing.
Related ICD-10 Codes Often Used with Anaplastic large cell lymphoma, ALK-positive, spleen
- C84.66 – Anaplastic large cell lymphoma, ALK-negative, spleen
- C83.71 – Diffuse large B-cell lymphoma, spleen
ICD-10 Code C84.67 in Medical Billing and Insurance for Anaplastic large cell lymphoma, ALK-positive, spleen
ICD-10 Code C84.67 is crucial for accurate billing in hospital, ER, or oncology settings, ensuring proper reimbursement for services rendered.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
- Use C84.67 in inpatient and outpatient settings where ALK-positive ALCL is diagnosed.
- Ensure that all chart elements, including lab results and imaging, are included in documentation.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count with automated differential. |
| 77014 | Radiologic guidance for needle placement. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C84.67 for Anaplastic large cell lymphoma, ALK-positive, spleen
What are the common symptoms of Anaplastic large cell lymphoma, ALK-positive?
Common symptoms include lymphadenopathy, splenomegaly, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and general malaise.
How is Anaplastic large cell lymphoma, ALK-positive diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy with immunohistochemical analysis to detect ALK gene rearrangements.
What is the treatment for Anaplastic large cell lymphoma, ALK-positive?
Treatment usually involves chemotherapy regimens, possibly combined with targeted therapies such as ALK inhibitors. Supportive care is also critical to manage symptoms.
Why is accurate coding important for Anaplastic large cell lymphoma, ALK-positive?
Accurate coding ensures appropriate reimbursement, facilitates effective patient management, and supports public health reporting and research initiatives.
